Crotamiton

CHEMBL6067975 Phase 4 Approved Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
203.3 g/mol
LogP
2.8
Phase
4

A topical agent with both antiparasitic and antipruritic properties used to treat scabies and relieve itching from various skin conditions. Its precise mechanism of action is not fully established, but it is applied to the skin to kill the Sarcoptes scabiei mite.

Molecular Weight

203.2800 g/mol

LogP

2.80

TPSA

20.30 Ų

Lipinski RO5

Pass

Mechanism of Action

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(C1=CC=CC=C1C)C(=O)C=CC

InChI

InChI=1S/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3

Molecular Formula

C13H17NO

HBD / HBA

- / 1

Rotatable Bonds

3

Heavy Atoms

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A topical agent with both antiparasitic and antipruritic properties used to treat scabies and relieve itching from various skin conditions. Its precise mechanism of action is not fully established, but it is applied to the skin to kill the Sarcoptes scabiei mite.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Crotamiton is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6067975. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2883. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.